News Releases

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

Anixa Biosciences to Present at Artificial Intelligence Conference

October 5, 2018

ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX

September 28, 2018

Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy

September 5, 2018

ITUS Corporation to Present at Next Generation Dx Summit

August 17, 2018

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

August 1, 2018

ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

July 30, 2018

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

July 6, 2018

Latest News & Events

Sep 14, 2021

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium

Read More...

Sep 8, 2021

Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Read More...

Sep 7, 2021

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

Read More...